Search Bar & Filters
Found 6 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
Actively Recruiting
Dystrophic Epidermolysis Bullosa DEB is a rare genetic skin disease causing fragile skin that blisters and bleeds easily, with severity ranging from mild to life-threatening. It results from mutations affecting collagen VII, which is essential for skin integrity. This trial evaluates the safety and effectiveness of a new cell-free therapy called Ev.FV, derived from mesenchymal stem cell extracellular vesicles, aiming to promote wound healing and skin regeneration in DEB patients. Participants will receive Ev.FV, a biological product containing five factors, through intravenous doses given six times every two weeks. These nanovesicles carry molecules that can reduce inflammation, stimulate skin cell growth, promote blood vessel formation, and potentially repair the skins anchoring structures. The study focuses on patients with chronic wounds sized between 10 and 50 square centimeters and includes assessments over several months to monitor wound healing and skin condition. During the trial, patients will undergo evaluations including wound closure rates measured at day 14, and skin disease activity scores at multiple time points up to six months. Pain levels will also be tracked using a visual scale over 30 days. Researchers will monitor safety, treatment effects, and how well the wounds heal. The total study duration includes follow-up visits to ensure comprehensive observation of the therapys impact.
Actively Recruiting
Researchers are investigating the potential of exosomes derived from mesenchymal stem cells MSCs as a treatment for osteoarthritis OA, a joint disorder marked by cartilage damage and inflammation. OA involves increased activity of enzymes like MMP and ADAMTS that degrade the joint matrix. MSCs have been studied for OA due to their ability to release beneficial factors, including exosomes that carry bioactive molecules and anti-inflammatory agents, which may help regulate joint cell behavior and slow OA progression. The study evaluates the effects of allogenic MSC-derived exosomes given through two intra-articular injections into the knees on day 1 and day 90. Participants have moderate to severe OA in both knees Kellgren-Lawrence grade 2 or 3 with mild to moderate pain and swelling. This approach aims to assess the therapeutic potential of these exosome injections over time. Participants will be monitored over 6 months, with evaluations at 1, 3, and 6 months after the first injection. The main outcome measure is the Western Ontario and McMaster University Osteoarthritis Index WOMAC, which assesses pain, stiffness, and physical function. Researchers will observe changes following the initial and second injections, tracking the treatments impact on symptoms and joint health.
Actively Recruiting
Researchers are studying how individual health behaviors and broader societal factors like environment, policies, and health system quality affect health outcomes such as death and the development of chronic diseases. This study also explores genetic influences on non-communicable diseases through both a cross-sectional and a prospective cohort approach. It aims to understand these relationships across different socioeconomic and health resource settings worldwide. Participants are adults aged 35 to 70 years at enrollment. The study involves observing various health-related behaviors, societal determinants including built environment, food and nutrition policies, psychosocial and socioeconomic factors, and tobacco use. Researchers will track the incidence of chronic diseases like cardiovascular disease, cancer, respiratory conditions, diabetes, kidney disease, obesity, hypertension, and injuries over time, without administering any specific treatments. Participants will be followed for an average of 10 years, during which researchers will monitor health events such as new cases of cardiovascular disease and other illnesses, hospitalizations, and mortality. Data will be collected on genetic factors and changes in risk factors like smoking and diet. The study measures the impact of health systems and environmental influences on outcomes. Participants will be involved through regular assessments but will not receive interventions as this is an observational study.
Actively Recruiting
Researchers are studying adults with end-stage renal disease ESRD who are receiving maintenance hemodialysis to evaluate the effects of a 12-week supervised intradialytic multimodal exercise program on postural abnormalities like thoracic hyperkyphosis and forward head posture. These postural issues are common in dialysis patients and contribute to falls, reduced mobility, and impaired physical function. This randomized, assessor-blinded controlled trial aims to provide preliminary data on the safety and potential benefits of incorporating postural correction exercises into routine dialysis care. Participants will be randomly assigned to either the intradialytic exercise group or a control group receiving usual care. Those in the exercise group will perform supervised exercises three times per week during their scheduled dialysis sessions, including postural correction, resistance-band strengthening, core stabilization, stretching, breathing exercises, and seated aerobic cycling. Each session lasts 40-45 minutes during the second hour of dialysis and is overseen by a qualified exercise physiologist or physical therapist. The control group will continue their standard nephrological care without additional exercise instruction. Throughout the 12 weeks, researchers will assess changes in thoracic kyphosis angle and craniovertebral angle, as well as balance, mobility, functional exercise capacity, gait speed, physical activity level, adherence, and any adverse events. Participants will be monitored for safety, and assessments will occur at baseline and after the 12-week program. The study will help determine the feasibility and clinical value of adding postural correction exercises to hemodialysis treatment schedules.
Actively Recruiting
Healthy Volunteer
Keratoconus is an eye condition that causes changes in the shape of the cornea, often affecting both eyes unevenly and leading to vision problems. This research aims to find out how common keratoconus is among children and teenagers worldwide. Researchers believe that the number of people with keratoconus may be higher than previous studies have shown. Participants will have a one-time eye exam using a special imaging device called the Pentacam HR, which creates detailed 3D images of the front part of the eye. During this visit, participants and their parents or guardians will complete a questionnaire about risk factors for keratoconus. This study involves children and adolescents aged 6 to 23 years who are visiting medical centers for reasons other than eye problems. Participants will attend a single visit where the eye imaging test and questionnaire take about 15 minutes. The researchers will use the images and information collected to determine how often keratoconus occurs in this age group. The study is observational, meaning it collects data without providing treatment, and participants will be involved only during this single visit.